Ryan Kopp, M.D.

  • Associate Professor of Urology, School of Medicine

Education and training

  • Degrees

    • M.D., 2007, Indiana University School of Medicine
  • Residency

    • Urology, University of California San Diego, 2013
  • Fellowship

    • Urologic oncology, Memorial Sloan Kettering Cancer Center, 2015

Publications

Elsevier pure profile

Publications

  • A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer

    European Urology Oncology
    1. Brant A. Inman
    2. Noah M. Hahn
    3. Kelly Stratton
    4. Ryan Kopp
    5. Alex Sankin
    6. Eila Skinner
    7. Kamal Pohar
    8. Benjamin A. Gartrell
    9. Song Pham
    10. Deepali Rishipathak
    11. Sanjeev Mariathasan
    12. Nicole Davarpanah
    13. Corey Carter
    14. Gary D. Steinberg
  • Metabolic activity diffusion imaging (MADI)

    NMR in biomedicine
    1. Charles S. Springer
    2. Eric M. Baker
    3. Xin Li
    4. Brendan Moloney
    5. Martin M. Pike
    6. Gregory J. Wilson
    7. Valerie C. Anderson
    8. Manoj K. Sammi
    9. Mark G. Garzotto
    10. Ryan P. Kopp
    11. Fergus V. Coakley
    12. William D. Rooney
    13. Jeffrey H. Maki
  • Calibrated Regression Models Based on the Risk of Clinical Nodal Metastasis Should be Used as Decision Aids for Prostate Cancer Staging to Reduce Unnecessary Imaging

    Clinical Genitourinary Cancer
    1. Mitchell Hayes
    2. Yun Yu
    3. Solange Bassale
    4. Nicholas Chakiryan
    5. Yiyi Chen
    6. Shangyuan Ye
    7. Mark Garzotto
    8. Ryan Kopp
  • SNPs at SMG7 Associated with Time from Biochemical Recurrence to Prostate Cancer Death

    Cancer Epidemiology Biomarkers and Prevention
    1. Xiaoyu Song
    2. Meng Ru
    3. Zoe Steinsnyder
    4. Kaitlyn Tkachuk
    5. Ryan P. Kopp
    6. John Sullivan
    7. Zeynep H. Gümüş
    8. Kenneth Offit
    9. Vijai Joseph
    10. Robert J. Klein
  • Epigenetic loss of heterogeneity from low to high grade localized prostate tumours

    Nature communications
    1. Sebnem Ece Eksi
    2. Alex Chitsazan
    3. Zeynep Sayar
    4. George V. Thomas
    5. Andrew J. Fields
    6. Ryan P. Kopp
    7. Paul T. Spellman
    8. Andrew C. Adey
  • Survival outcomes and practice trends for off-label use of adjuvant targeted therapy in high-risk locoregional renal cell carcinoma

    Urologic Oncology: Seminars and Original Investigations
    1. Nicholas H. Chakiryan
    2. Ann Martinez Acevedo
    3. Mark A. Garzotto
    4. Yiyi Chen
    5. Jen Jane Liu
    6. Sudhir Isharwal
    7. Christopher L. Amling
    8. Ryan P. Kopp
  • Dairy product consumption and prostate cancer risk in the United States

    Nutrients
    1. Isabella Preble
    2. Zhenzhen Zhang
    3. Ryan Kopp
    4. Mark Garzotto
    5. Gerd Bobe
    6. Jackilen Shannon
    7. Yumie Takata
  • Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes

    Journal of Urology
    1. Nicholas Chakiryan
    2. Ann Martinez
    3. Lina Gao
    4. Jen Jane Liu
    5. Christopher Amling
    6. Mark Garzotto
    7. Ryan P. Kopp
  • Polymorphisms in oxidative stress pathway genes and prostate cancer risk

    Cancer Causes and Control
    1. Zhenzhen Zhang
    2. Duo Jiang
    3. Chi Wang
    4. Mark Garzotto
    5. Ryan Kopp
    6. Beth Wilmot
    7. Philippe Thuillier
    8. Andy Dang
    9. Amy Palma
    10. Paige E. Farris
    11. Jackilen Shannon
  • The estimated prevalence of missed positive lymph nodes based on extent of lymphadenectomy at radical prostatectomy

    Urologic Oncology: Seminars and Original Investigations
    1. Nicholas H. Chakiryan
    2. Ann Martinez Acevedo
    3. Michael J. Conlin
    4. Mark Garzotto
    5. Yiyi Chen
    6. Jen Jane Liu
    7. Christopher L. Amling
    8. Ryan P. Kopp
  • Prophylactic antibiotics following radical cystectomy reduces urinary tract infections and readmission for sepsis from a urinary source

    Urologic Oncology: Seminars and Original Investigations
    1. Ryan P. Werntz
    2. Ann Martinez-Acevedo
    3. Hamed Amadi
    4. Ryan Kopp
    5. Jeffrey La Rochelle
    6. Theresa Koppie
    7. Christopher Amling
    8. Kamran P. Sajadi
  • Unconventional Bladder Preservation

    Journal of Urology
    1. Akash A. Kapadia
    2. Ann Martinez Acevedo
    3. Jen Jane Liu
    4. Mark Garzotto
    5. Michael Conlin
    6. Christopher Amling
    7. Ryan P. Kopp
  • Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy

    Urology
    1. Ryan P. Kopp
    2. Michael Chevinsky
    3. Melanie Bernstein
    4. George Bosl
    5. Robert Motzer
    6. Dean Bajorin
    7. Darren Feldman
    8. Brett S. Carver
    9. Joel Sheinfeld
  • Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma

    Cancer
    1. Ryan P. Kopp
    2. Kelly L. Stratton
    3. Emily Glogowski
    4. Kasmintan A. Schrader
    5. Rohini Rau-Murthy
    6. Paul Russo
    7. Jonathan A. Coleman
    8. Kenneth Offit
  • Analysis of Renal Functional Outcomes after Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score

    Urology
    1. Ryan P. Kopp
    2. Michael A. Liss
    3. Reza Mehrazin
    4. Song Wang
    5. Hak J. Lee
    6. Ramzi Jabaji
    7. Hossein S. Mirheydar
    8. Kyle Gillis
    9. Nishant Patel
    10. Kerrin L. Palazzi
    11. Jim Y. Wan
    12. Anthony L. Patterson
    13. Ithaar H. Derweesh
  • An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality

    British Journal of Cancer
    1. J. Sullivan
    2. R. Kopp
    3. K. Stratton
    4. C. Manschreck
    5. M. Corines
    6. R. Rau-Murthy
    7. J. Hayes
    8. A. Lincon
    9. A. Ashraf
    10. T. Thomas
    11. K. Schrader
    12. D. Gallagher
    13. R. Hamilton
    14. H. Scher
    15. H. Lilja
    16. P. Scardino
    17. J. Eastham
    18. K. Offit
    19. J. Vijai
    20. R. J. Klein
  • Association of rise in C-reactive protein with decline in renal function following partial nephrectomy

    Canadian Journal of Urology
    1. Seth A. Cohen
    2. Ryan P. Kopp
    3. Kerrin L. Palazzi
    4. Michael A. Liss
    5. Reza Mehrazin
    6. Jason Woo
    7. Hak J. Lee
    8. Ramzi Jabaji
    9. Kyle Gillis
    10. Song Wang
    11. Robert W. Wake
    12. Anthony L. Patterson
    13. Ithaar H. Derweesh
  • Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of european ancestry

    Human molecular genetics
    1. Jonine D. Figueroa
    2. Candace D. Middlebrooks
    3. A. Rouf Banday
    4. Yuanqing Ye
    5. Montserrat Garcia-Closas
    6. Nilanjan Chatterjee
    7. Stella Koutros
    8. Lambertus A. Kiemeney
    9. Thorunn Rafnar
    10. Timothy Bishop
    11. Helena Furberg
    12. Giuseppe Matullo
    13. Klaus Golka
    14. Manuela Gago-Dominguez
    15. Jack A. Taylor
    16. Tony Fletcher
    17. Afshan Siddiq
    18. Victoria K. Cortessis
    19. Charles Kooperberg
    20. Olivier Cussenot
    21. Simone Benhamou
    22. Jennifer Prescott
    23. Stefano Porru
    24. Colin P. Dinney
    25. Núria Malats
    26. Dalsu Baris
    27. Mark P. Purdue
    28. Eric J. Jacobs
    29. Demetrius Albanes
    30. Zhaoming Wang
    31. Charles C. Chung
    32. Sita H. Vermeulen
    33. Katja K. Aben
    34. Tessel E. Galesloot
    35. Gudmar Thorleifsson
    36. Patrick Sulem
    37. Kari Stefansson
    38. Anne E. Kiltie
    39. Mark Harland
    40. Mark Teo
    41. Kenneth Offit
    42. Joseph Vijai
    43. Dean Bajorin
    44. Ryan Kopp
    45. Giovanni Fiorito
    46. Simonetta Guarrera
    47. Carlotta Sacerdote
    48. Silvia Selinski
    49. Jan G. Hengstler
    50. Holger Gerullis
    51. Daniel Ovsiannikov
    52. Meinolf Blaszkewicz
    53. Jose Esteban Castelao
    54. Manuel Calaza
    55. Maria Elena Martinez
    56. Patricia Cordeiro
    57. Zongli Xu
    58. Vijayalakshmi Panduri
    59. Rajiv Kumar
    60. Eugene Gurzau
    61. Kvetoslava Koppova
    62. H. Bas Bueno-De-Mesquita
    63. Börje Ljungberg
    64. Françoise Clavel-Chapelon
    65. Elisabete Weiderpass
    66. Vittorio Krogh
    67. Miren Dorronsoro
    68. Ruth C. Travis
    69. Anne Tjønneland
    70. Paul Brennan
    71. Jenny Chang-Claude
    72. Elio Riboli
    73. David Conti
    74. Marianna C. Stern
    75. Malcolm C. Pike
    76. David Van Den Berg
    77. Jian Min Yuan
    78. Chancellor Hohensee
    79. Rebecca P. Jeppson
    80. Geraldine Cancel-Tassin
    81. Morgan Roupret
    82. Eva Comperat
    83. Constance Turman
    84. Immaculata De Vivo
    85. Edward Giovannucci
    86. David J. Hunter
    87. Peter Kraft
    88. Sara Lindstrom
    89. Angela Carta
    90. Sofia Pavanello
    91. Cecilia Arici
    92. Giuseppe Mastrangelo
    93. Ashish M. Kamat
    94. Liren Zhang
    95. Yilei Gong
    96. Xia Pu
    97. Amy Hutchinson
    98. Laurie Burdett
    99. William A. Wheeler
    100. Margaret R. Karagas
    101. Alison Johnson
    102. Alan Schned
    103. G. M. Monawar Hosain
    104. Molly Schwenn
    105. Manolis Kogevinas
    106. Adonina Tardón
    107. Consol Serra
    108. Alfredo Carrato
    109. Reina García-Closas
    110. Josep Lloreta
    111. Gerald Andriole
    112. Grubb Robert
    113. Amanda Black
    114. W. Ryan Diver
    115. Susan M. Gapstur
    116. Stephanie Weinstein
    117. Jarmo Virtamo
    118. Christopher A. Haiman
    119. Maria Teresa Landi
    120. Neil E. Caporaso
    121. Fraumeni Joseph
    122. Paolo Vineis
    123. Xifeng Wu
    124. Stephen J. Chanock
    125. Debra T. Silverman
    126. Ludmila Prokunina-Olsson
    127. Nathaniel Rothman
  • Determinants of renal functional decline after open partial nephrectomy

    Canadian Journal of Urology
    1. Ramzi Jabaji
    2. Kerrin L. Palazzi
    3. Reza Mehrazin
    4. Seth A. Cohen
    5. James H. Masterson
    6. Jason R. Woo
    7. Hak Lee
    8. Michael A. Liss
    9. Ryan P. Kopp
    10. Song Wang
    11. Sean P. Stroup
    12. Anthony L. Patterson
    13. James O. L'Esperance
    14. Ithaar H. Derweesh
  • Impact of renal surgery for cortical neoplasms on lipid metabolism

    BJU international
    1. Aditya Bagrodia
    2. Ryan P. Kopp
    3. Reza Mehrazin
    4. Hak J. Lee
    5. Michael A. Liss
    6. Ramzi Jabaji
    7. Christopher J. Kane
    8. Robert W. Wake
    9. Anthony L. Patterson
    10. Jim Y. Wan
    11. Ithaar H. Derweesh
  • Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score

    BJU international
    1. Ryan P. Kopp
    2. Reza Mehrazin
    3. Kerrin L. Palazzi
    4. Michael A. Liss
    5. Ramzi Jabaji
    6. Hossein S. Mirheydar
    7. Hak J. Lee
    8. Nishant Patel
    9. Fuad Elkhoury
    10. Anthony L. Patterson
    11. Ithaar H. Derweesh
  • Comparison of transrectal and transvaginal hybrid natural orifice transluminal endoscopic surgery partial nephrectomy in the porcine model

    Urology
    1. Wassim M. Bazzi
    2. Sean P. Stroup
    3. Seth A. Cohen
    4. David M. Sisul
    5. Michael A. Liss
    6. James H. Masterson
    7. Ryan P. Kopp
    8. Suzanne R. Gudeman
    9. Elisabeth Leeflang
    10. Kerrin L. Palazzi
    11. Sonia Ramamoorthy
    12. Christopher J. Kane
    13. Santiago Horgan
    14. Ithaar H. Derweesh
  • Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula

    Canadian Journal of Urology
    1. Ryan P. Kopp
    2. Lejla Aganovic
    3. Kerrin L. Palazzi
    4. Fiona H. Cassidy
    5. Kyoko Sakamoto
    6. Ithaar H. Derweesh
  • Does radical nephrectomy increase the risk of erectile dysfunction compared with partial nephrectomy? A cohort analysis

    BJU international
    1. Ryan P. Kopp
    2. Brian M. Dicks
    3. Irwin Goldstein
    4. Reza Mehrazin
    5. Jonathan L. Silberstein
    6. Caroline J. Colangelo
    7. Aditya Bagrodia
    8. Wassim M. Bazzi
    9. Robert W. Wake
    10. Anthony L. Patterson
    11. Christopher J. Kane
    12. Jim Y. Wan
    13. Ithaar H. Derweesh
  • Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study

    Urology
    1. Sean P. Stroup
    2. Omer A. Raheem
    3. Kerrin L. Palazzi
    4. Michael A. Liss
    5. Reza Mehrazin
    6. Ryan P. Kopp
    7. Nishant Patel
    8. Seth A. Cohen
    9. Samuel K. Park
    10. Anthony L. Patterson
    11. Christopher J. Kane
    12. Frederick Millard
    13. Ithaar H. Derweesh
  • Impact of tumour morphology on renal function decline after partial nephrectomy

    BJU international
    1. Reza Mehrazin
    2. Kerrin L. Palazzi
    3. Ryan P. Kopp
    4. Caroline J. Colangelo
    5. Sean P. Stroup
    6. James H. Masterson
    7. Michael A. Liss
    8. Seth A. Cohen
    9. Ramzi Jabaji
    10. Samuel K. Park
    11. Anthony L. Patterson
    12. James O. L'Esperance
    13. Ithaar H. Derweesh